2-(5,6-二甲基-1H-苯并咪唑-2-基)胍 | 111692-93-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 中文名称: 2-(5,6-二甲基-1H-苯并咪唑-2-基)胍
• 英文名称: N''-(5,6-dimethyl-1H-benzimidazol-2-yl)guanidine
• 英文别名: 2-(5,6-dimethyl-1H-benzimidazol-2-yl)guanidine
• CAS: 111692-93-4；41927-06-4
• 化学式: C₁₀H₁₃N₅
• mdl: MFCD00087632
• 分子量: 203.247
• InChiKey: ITKFRENCGKAVOT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  93.1
• 氢给体数：
  3
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(5,6-二甲基-1H-苯并咪唑-2-基)胍 以 甲醇 、 氨 、 二甲基亚砜 为溶剂， 生成 [bis(N''-(5,6-dimethyl-1H-benzimidazol-2-yl)guanidinato)nickel(II)] (dimethylsulfoxide)2 semihydrate
  参考文献：
  名称：

  A comparative study of supramolecular assemblies containing N″-(5,6-dimethyl-1H-benzimidazol-2-yl)guanidine, 2-guanidinobenzimidazole and their Ni(II) complexes

  摘要：

  Previous studies have, shown that 2-guanidinobenzimidazole and the neutral complex [bis(2-guanidinobenzimidazolo)nickel(II)] are capable of forming extended hydrogen bonded arrays in the solid state, either alone or with other transition metal complexes as well as with organic molecules with complementary hydrogen bonding motifs. Additionally, the complex of the free ligand with phthalimide contains a NH-N hydrogen bond so short that it compares with the short hydrogen bonds in some of the 'proton sponges'. In this paper we report on the molecular structures and simple supramolecular assemblies containing the related ligand N"-(5,6-dimethyl-1H-benzimidazol-2-yl)guanidine which has a higher pK(a) than the parent (unsubstituted) ligand and which has steric requirements which mean that it cannot be incorporated into the same supramolecular structures. In particular, we examine the structure of the free ligand, of the complex formed by the ligand and phthalimide and of the extended structure of the neutral bis-ligand nickel(II) complex and dmso. The structures are compared with those mentioned above incorporating the unsubstituted ligand, 2-guanidinobenzimidazole. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0277-5387(02)01404-3
• 作为产物：
  描述：

  4，5-二甲基-1，2-苯二胺 、 二聚氰胺 在 盐酸 、 水 作用下， 生成 2-(5,6-二甲基-1H-苯并咪唑-2-基)胍
  参考文献：
  名称：

  276.环六-1：3-二酮的制备：对醛的表征的试剂

  摘要：

  DOI：

  10.1039/jr9480001371

文献信息

• Cobalt-catalyzed isocyanide insertion cyclization to dihydrobenzoimidazotriazins
  作者：Fereshteh Ahmadi、Peiman Mirzaei、Ayoob Bazgir

  DOI：10.1016/j.tetlet.2017.09.088

  日期：2017.11

  We have developed an isocyanide insertion reaction for the synthesis of dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazins and imidazol-quinoxaline-5-carboxamides utilizing cobalt catalyst. Cobalt-catalyzed system is inexpensive and more acceptable from industrial point of view.

  我们已经开发了一种异氰酸酯插入反应，用于利用钴催化剂合成二氢苯并[4,5]咪唑并[1,2- a ] [1,3,5]三嗪和咪唑-喹喔啉-5-甲酰胺。钴催化的系统便宜且从工业角度来看更可接受。
• 2-amino-5-pyrimidine acetic acid compounds
  申请人：Pharmacia AB

  公开号：US06329383B1

  公开（公告）日：2001-12-11

  The present invention relates to new benzimidazole compounds with the following general structure (I): in which Y—X is >C═X when X is NR8, O, or S and R2 is H, alkyl, substituted alkylaryl or substituted aryl; or Y—X is >C—X when X is H, alkyl, substituted alkyl, aryl, substituted aryl, OR9 or NHR9 and R2 is a bond to Y; Z is O, S or NR12; R1 is H, alkyl, substituted alkyl, aryl or substituted aryl; R3 is H, alkyl, substituted alkyl, aryl or substituted aryl, OR9 or NHR9; R4, R5, R6 and R7 are H, halogen, OR10, NR10, R11, NO2, CF3, CN, COR8, COOR8, CONHR8 and/or N3 in any combination and/or two adjacent R4, R5, R6 or R7 form a carbocyclic or heterocyclic ring; and R8, R9, R10, R11, R12 and R13 are H, alkyl, substituted alkylaryl, aryl and/or substituted aryl in any combination. These compounds are useful as a human Growth Hormone (hGH) mimetic, which trigger GH agonist effects in animals and especially as an orally available human Growth Hormone (hGH).

  本发明涉及具有以下一般结构（I）的新苯并咪唑类化合物：其中当X为NR8，O或S且R2为H，烷基，取代烷基芳基或取代芳基时，Y-X为>C═X；或当X为H，烷基，取代烷基，芳基，取代芳基，OR9或NHR9时，Y-X为>C-X且R2为与Y的键；Z为O，S或NR12；R1为H，烷基，取代烷基，芳基或取代芳基；R3为H，烷基，取代烷基，芳基或取代芳基，OR9或NHR9；R4，R5，R6和R7为H，卤素，OR10，NR10，R11，NO2，CF3，CN，COR8，COOR8，CONHR8和/或N3的任意组合和/或相邻的两个R4，R5，R6或R7形成一个碳环或杂环；R8，R9，R10，R11，R12和R13为H，烷基，取代烷基芳基，芳基和/或取代芳基的任意组合。这些化合物可用作人类生长激素（hGH）类似物，可在动物中引发GH激动剂效应，特别是作为口服可用的人类生长激素（hGH）。
• [EN] NON-PEPTIDE G-CSF MIMETICS<br/>[FR] MINETIQUE DU G-CSF NON PEPTIDIQUE
  申请人：SMITHKLINE BEECHAM CORPORATION

  公开号：WO1997044033A1

  公开（公告）日：1997-11-27

  (EN) Invented are non-peptide G-CSF mimetics. Also invented are substitued 2,5-Diimino-3a,6a-diaryl-1,2,3,3a,4,5,6,6a-octahydroimidazo[4,5-d]imidazoles, pharmaceutical compositions containing these compounds, and methods of using these compounds as G-CSF mimetics. Also invented are novel processes used in preparing these compounds.(FR) L'invention concerne des composés mimétiques du G-CSF non peptidiques. L'invention décrit également des 2,5-diimino-3a,6a-diaryl-1,2,3,3a,4,5,6,6a-octahydroimidazo[4,5-d]imidazoles substitués, des compositions pharmaceutiques contenant ces composés et des procédés d'utilisation desdits composés comme composés mimétiques du G-CSF. L'invention concerne en outre de nouveaux procédés utilisés dans la préparaiton desdits composés.

  已发明非肽G-CSF模拟剂。还发明了取代的2,5-二氨基-3a,6a-二芳基-1,2,3,3a,4,5,6,6a-八氢咪唑[4,5-d]咪唑，包含这些化合物的药物组合物，以及将这些化合物用作G-CSF模拟剂的方法。还发明了用于制备这些化合物的新工艺。
• Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof
  申请人：Brown R. Truman

  公开号：US20060089316A1

  公开（公告）日：2006-04-27

  Disclosed are methods of using various compounds, which are known to bind to 3-deoxyglucosone (3DG) or precursors thereof, in order to reduce a susceptibility to tumor formation and/or to prevent or delay onset of tumor formation induced by 3DG and its precursors. Also disclosed is the reduction of 3DG levels in high fructose corn syrop so that the high fructose corn syrup is less likely to induce tumor formation.

  公开了使用各种已知与3-脱氧葡萄糖酮（3DG）或其前体结合的化合物的方法，以减少对肿瘤形成的易感性和/或预防或延迟由3DG及其前体诱导的肿瘤形成。还公开了降低高果糖玉米糖浆中3DG水平的方法，以使高果糖玉米糖浆不太可能诱导肿瘤形成。
• Cleaning formulation for removing residues on surfaces
  申请人：Fujifilm Electronic Materials U.S.A., Inc.

  公开号：US10253282B2

  公开（公告）日：2019-04-09

  This disclosure relates to a cleaning composition that contains 1) at least one redox agent; 2) at least one first chelating agent, the first chelating agent being a polyaminopolycarboxylic acid; 3) at least one second chelating agent different from the first chelating agent, the second chelating agent containing at least two nitrogen-containing groups; 4) at least one metal corrosion inhibitor, the metal corrosion inhibitor being a substituted or unsubstituted benzotriazole; 5) at least one organic solvent selected from the group consisting of water soluble alcohols, water soluble ketones, water soluble esters, and water soluble ethers; 6) water; and 7) optionally, at least one pH adjusting agent, the pH adjusting agent being a base free of a metal ion. This disclosure also relates to a method of using the above composition for cleaning a semiconductor substrate.

  本公开涉及一种清洁组合物，其中包含：1）至少一种氧化还原剂；2）至少一种第一螯合剂，第一螯合剂为聚氨基多羧酸；3）至少一种不同于第一螯合剂的第二螯合剂，第二螯合剂含有至少两个含氮基团；4) 至少一种金属缓蚀剂，该金属缓蚀剂为取代或未取代的苯并三唑； 5) 至少一种有机溶剂，该有机溶剂选自由水溶性醇、水溶性酮、水溶性酯和水溶性醚组成的组； 6) 水；以及 7) 可选地，至少一种 pH 值调节剂，该 pH 值调节剂为不含金属离子的碱。本公开还涉及一种使用上述组合物清洗半导体基底的方法。